Abstract:OBJECTIVES:The expression level of Ubiquitin-conjugating enzyme E2T (UBE2T) is upregulated in various types of human tumors. We explored the correlation and regulatory mechanism of UBE2T in the development of colorectal cancer (CRC).METHODS:Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was used to examine the expression of UBE2T in the CRC tissues and cell lines. Immunohistochemical staining, spearman correlation analysis, and Kaplan Meier-survival analysis were used to demonstrate the correlation between UBE2T high expression level and the clinical characteristics of malignant patients and the overall survival. The proliferation, apoptosis, migration and invasion of CRC cells were analyzed by cell transfection, MTT, colony formation, scratch assay, transwell, and flow cytometry. Furthermore, the expression of cell proliferation and apoptosis related proteins and ubiquitination of p53 were detected by western blot.RESULTS:UBE2T was up-regulated in CRC tissues and cell lines, and high expression level of UBE2T was correlated with the clinical characteristics of malignant of CRC patients (P<0.05), and patients with high expression level of UBE2T had lower overall survival (P=0.0455). In addition, UBE2T could promote the growth, proliferation, invasion and metastasis of CRC cells and inhibit the apoptosis. At the same time, knockdown of UBE2T inhibited the growth of transplanted tumor in mice of subcutaneous CRC model. Moreover, our experimental results proved that UBE2T regulated the expression of downstream related proteins through ubiquitination of p53 protein to promote the occurrence and development of CRC.CONCLUSION:Our study elucidated that high expression of UBE2T would enhance the development of CRC, and then further explored its molecular mechanism both in vitro and in vivo. The results indicated that UBE2T facilitated ubiquitination and degradation of p53, which predicts the possibility of UBE2T as one of molecular diagnosis markers, prognostic indicators and therapeutic drug targets of CRC patients.

PTBP3 Modulates P53 Expression and Promotes Colorectal Cancer Cell Proliferation by Maintaining UBE4A Mrna Stability

The E3 Ligase Ring1 Targets P53 For Degradation And Promotes Cancer Cell Proliferation And Survival

Data from Genetic Ablation of <i>rbm38</i> Promotes Lymphomagenesis in the Context of Mutant P53 by Downregulating PTEN

PIM3 Functions As Oncogenic Factor and Promotes the Tumor Growth and Metastasis in Colorectal Cancer

The transcription factor PBX3 promotes tumor cell growth through transcriptional suppression of the tumor suppressor p53

USP36 promotes colorectal cancer progression through inhibition of p53 signaling pathway via stabilizing RBM28

LncRNA SUMO1P3 promotes proliferation and inhibits apoptosis in colorectal cancer by epigenetically silencing CPEB3

Ubiquitin-conjugating Enzyme E2T(UBE2T) Promotes Colorectal Cancer Progression by Facilitating Ubiquitination and Degradation of P53.

Mex-3 RNA binding family member A (MEX3A)/circMPP6 complex promotes colorectal cancer progression by inhibiting autophagy

New Insights Into PTBP3 in Human Cancers: Immune Cell Infiltration, TMB, MSI, PDCD1 and m6A Markers

BATF3 promotes malignant phenotype of colorectal cancer through the S1PR1/p-STAT3/miR-155-3p/WDR82 axis

UBE2J1 inhibits colorectal cancer progression by promoting ubiquitination and degradation of RPS3

Ubiquitin-Specific Protease 4-Mediated Deubiquitination and Stabilization of PRL-3 is Required for Potentiating Colorectal Oncogenesis.

SETBP1 Activation Upon MDM4-enhanced Ubiquitination of NR3C1 Triggers Dissemination of Colorectal Cancer Cells

BPTF inhibition antagonizes colorectal cancer progression by transcriptionally inactivating Cdc25A

Disruption of PABPN1 phase separation by SNRPD2 drives colorectal cancer cell proliferation and migration through promoting alternative polyadenylation of CTNNBIP1

PTBP1 Regulates DNMT3B Alternative Splicing by Interacting With RALY to Enhance the Radioresistance of Prostate Cancer

Polypyrimidine Tract-Binding Protein 1 Promotes Proliferation, Migration and Invasion in Clear-Cell Renal Cell Carcinoma by Regulating Alternative Splicing of PKM.

Dual roles of TRIM3 in colorectal cancer by retaining p53 in the cytoplasm to decrease its nuclear expression

Molecular Characterization and Clinical Relevance of RNA Binding Proteins in Colorectal Cancer